The Group of Eight (G8) has expressed commitment to improve surveillance for infectious diseases and to improve transparency by all countries Media release 02 February 2013 Pages: 2 - 2
Mylan Laboratories has testified before the US Senate Special Committee on Aging on the tactics used by brand pharmaceutical companies Media release 02 February 2013 Pages: 2 - 2
A report commissioned by the Dutch government says that treatments which cost > euro80 000 for every extra quality-adjusted life year should not be covered News item 02 February 2013 Pages: 3 - 3
Sildenafil is more cost effective than bosentan for the treatment of pulmonary hypertension, Clinical study 02 February 2013 Pages: 3 - 3
The costs of medical care for patients with severe chronic illness varies across the US, but quality of care is not necessarily related to cost of care, News item 02 February 2013 Pages: 4 - 4
Lamivudine monotherapy best bet in preventing HBV recurrence Clinical study 02 February 2013 Pages: 4 - 4
Off-label drug prescribing high in hospitalised children Clinical study 02 February 2013 Pages: 5 - 5
No advantages to CBT in benzodiazepine tapering strategies Clinical study 02 February 2013 Pages: 6 - 6
People with depression who have limited access to care incur higher annual costs than those with less limited access, Media release 02 February 2013 Pages: 6 - 6
Sitaxsentan sodium appears to be more cost effective than bosentan in treating patients with pulmonary arterial hypertension (PAH), Clinical study 02 February 2013 Pages: 7 - 7
Supply rate of antihypertensives affects hospitalisation and costs Clinical study 02 February 2013 Pages: 7 - 7
Dexmedetomidine a beneficial addition to postoperative sedation Clinical study 02 February 2013 Pages: 7 - 7
Delayed antibacterials best for infectious conjunctivitis? Clinical study 02 February 2013 Pages: 8 - 8
The combined osteoporosis treatment alendronic acid/colecalciferol [Fosavance] is cost saving and more effective than ibandronic acid in postmenopausal women in The Netherlands, Clinical study 02 February 2013 Pages: 8 - 8
Migraine prophylaxis improves HRQOL and activity limitations Clinical study 02 February 2013 Pages: 9 - 9
Parallel importing of medicines in the UK led to healthcare savings of euro237 million in 2004, News item 02 February 2013 Pages: 10 - 10
Gilead Sciences is cutting the prices of its antiretroviral HIV drugs by nearly two-thirds in middle-income countries Media release 02 February 2013 Pages: 10 - 10
The Bill & Melinda Gates Foundation has announced the provision of 16 grants worth $US287 million dedicated to the acceleration of HIV/AIDS vaccine development, News item 02 February 2013 Pages: 11 - 11
The state medicines bill in Ireland is expected to drop by euro300 million following an agreement between the country's Health Services Executive and pharmacists, News item 02 February 2013 Pages: 11 - 11
New Zealand's pharmaceutical budget will increase by $NZ18 million* for the 2006−07 financial year, Media release 02 February 2013 Pages: 11 - 11